SCHEMBL13801139

SCHEMBL13801139

Cc1ccc(-c2nc3sc(-c4ccc(C)o4)nc3s2)o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 13/20 0.47
▸ ADORA1 P30542 13/20 0.47
▸ ADORA3 P0DMS8 5/20 0.47
▸ ADORA2B P29275 3/20 0.45
▸ TDP1 Q9NUW8 2/20 0.40
▸ MAPT P10636 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ PKM P14618 2/20 0.39
▸ RECQL P46063 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HTT P42858 2/20 0.35
▸ ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23954304 0.77 MAPT (0.42) ADORA2AADORA1ADORA3ADORA2BMAPT
SCHEMBL19135711 0.74 RAB9A (0.41) ADORA2AADORA1ADORA3ADORA2BTDP1
SCHEMBL12578009 0.71 TDP1 (0.67) ADORA2AADORA1TDP1MAPTALDH1A1
SCHEMBL11364130 0.71 ALDH1A1 (0.51) ADORA2AADORA1ADORA3TDP1MAPT
SCHEMBL25028051 0.69 ALDH1A1 (0.41) MAPTALDH1A1NPC1RAB9ALMNA
SCHEMBL21929982 0.69 TDP1 (0.62) ADORA2AADORA1TDP1MAPTALDH1A1
SCHEMBL10064162 0.69 TDP1 (0.62) ADORA2AADORA1TDP1MAPTALDH1A1
SCHEMBL14854115 0.69 TDP1 (0.48) ADORA2AADORA1ADORA3TDP1MAPT
SCHEMBL25028187 0.68 MMP2 (0.46) TDP1MAPTALDH1A1NPC1RAB9A
SCHEMBL13801136 0.68 KDM4E (0.44) ADORA2AADORA1ADORA3ADORA2BTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230050869-A1 THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH TOYO INK SC HOLDINGS CO., LTD. (JP) 2023-02-16 — — US disclosed
EP-3902021-A1 THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH Toyo Ink SC Holdings Co., Ltd. (JP) 2021-10-27 — — EP disclosed
US-20090156827-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT TOYO INK MFG. CO., LTD. (JP) 2009-06-18 — — US disclosed
US-20090156827-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT TOYO INK MFG. CO., LTD. (JP) 2009-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156827-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT ELP1, ELAVL1, ELF3 ADORA2A 3654/4885ADORA1 3020/4885ADORA3 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback